---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008878"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T14:26:34.669752+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals settles lawsuit with 62,500 shares, gets $100k loan from CEO trust at 18%

## Summary
- Entered settlement with 1800 Diagonal Lending, issuing 62,500 restricted shares to dismiss lawsuit with prejudice (May 5, 2025).
- Borrowed $100,000 from The Tiger Cub Trust (CEO-controlled) via 18% promissory note maturing May 2, 2026.
- Two Series B Preferred conversions: 100 shares for 73,333 common (Apr 28) and 300 shares for 220,000 common (May 1).
- Outstanding common shares now 11,034,023 after settlement and conversion issuances.

## SEC filing metadata
- accession: 0001641172-25-008878
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000164117225008878/0001641172-25-008878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000164117225008878/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008878
- JSON: https://secwatch.observer/filing/0001641172-25-008878.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008878.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.